Megumi Hirayama Selected Research

ketodihydrosphingosine

1/2018

Discovery of novel serine palmitoyltransferase inhibitors as cancer therapeutic agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Megumi Hirayama Research Topics

Disease

3	Neoplasms (Cancer) 01/2018 - 07/2017
2	Obesity 01/2017 - 01/2016
1	Non-alcoholic Fatty Liver Disease 08/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 07/2017
1	Insulin Resistance 01/2016
1	Hyperlipidemias (Hyperlipidemia) 01/2016
1	Hyperglycemia 01/2016
1	Fatty Liver 01/2016
1	Hypertension (High Blood Pressure) 10/2007

Drug/Important Bio-Agent (IBA)

2	Serine C-PalmitoyltransferaseIBA 01/2018 - 11/2017
2	LipidsIBA 11/2017 - 07/2017
2	stearoyl-coenzyme A (stearoyl-CoA)IBA 07/2017 - 01/2017
2	Triglycerides (Triacylglycerol)IBA 01/2016 - 01/2016
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 08/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2020
1	ketodihydrosphingosineIBA 01/2018
1	Pharmaceutical PreparationsIBA 11/2017
1	SphingolipidsIBA 11/2017
1	CeramidesIBA 11/2017
1	SphingomyelinsIBA 11/2017
1	T-3764518IBA 07/2017
1	oleoyl-coenzyme AIBA 07/2017
1	EnzymesIBA 07/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2017
1	Stearoyl-CoA DesaturaseIBA 07/2017
1	DiglyceridesIBA 01/2016
1	AcyltransferasesIBA 01/2016
1	Streptozocin (Streptozotocin)FDA Link 01/2016
1	MonoglyceridesIBA 01/2016
1	CytokinesIBA 10/2007
1	Receptor Activity-Modifying ProteinsIBA 10/2007

Therapy/Procedure

3	Therapeutics 01/2018 - 01/2016
1	Oral Administration 01/2018